BIOTON S.A. (WSE:BIO)
4.410
-0.050 (-1.12%)
Oct 3, 2025, 5:00 PM CET
BIOTON Market Cap
BIOTON has a market cap or net worth of 378.66 million as of October 3, 2025. Its market cap has increased by 29.71% in one year.
Market Cap
378.66M
Enterprise Value
422.95M
Revenue
265.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.41
Market Cap Chart
Since July 1, 2005, BIOTON's market cap has decreased from 1.09B to 378.66M, a decrease of -65.37%. That is a compound annual growth rate of -5.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 3, 2025 | 378.66M | 52.86% |
Dec 30, 2024 | 247.72M | -19.19% |
Dec 29, 2023 | 306.54M | 5.93% |
Dec 30, 2022 | 289.36M | -19.47% |
Dec 30, 2021 | 359.34M | -2.21% |
Dec 30, 2020 | 367.46M | 12.62% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Diagnostyka | 6.43B |
NEUCA | 3.04B |
Synektik Spólka Akcyjna | 2.19B |
Voxel | 1.78B |
Celon Pharma | 1.23B |
Selvita | 679.15M |
Centrum Medyczne ENEL-MED | 523.19M |
Ryvu Therapeutics | 520.38M |